Recombinant Thrombomodulin Has an Antitumor Effect and Enhances the Sensitivity of Gemcitabine Treatment of Pancreatic Cancer via G-protein Coupled Receptor 15

Authors

Kenei Furukawa, The Jikei University School of MedicineFollow
Jianhua Ling, The University of Texas MD Anderson Cancer Center
Yichen Sun, The University of Texas MD Anderson Cancer Center
Yu Lu, The University of Texas MD Anderson Cancer Center
Nathan Nguyen, The University of Texas MD Anderson Cancer Center
Pranavi Garlapati, The University of Texas MD Anderson Cancer Center
Paul J. Chiao, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

recombinant thrombomodulin, gemcitabine, GPR15, pancreatic cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

High School Summer Program

Recommended Citation

Furukawa, Kenei; Ling, Jianhua; Sun, Yichen; Lu, Yu; Nguyen, Nathan; Garlapati, Pranavi; and Chiao, Paul J., "Recombinant Thrombomodulin Has an Antitumor Effect and Enhances the Sensitivity of Gemcitabine Treatment of Pancreatic Cancer via G-protein Coupled Receptor 15" (2021). Summer Experience 2021. 217.
https://openworks.mdanderson.org/sumexp21/217